ENTITY
Sysmex Corp

Sysmex Corp (6869 JP)

89
Analysis
Health Care • Japan
SYSMEX CORPORATION manufactures reagents and equipment for clinical tests including hematologic (blood) and immune tests. The Company also develops, manufactures, and trades particle analyzers such as blood coagulation analyzer and related software. Manufacturing and sales outside Japan include the United States, EMEA, China and Asia Pacific regions.
more
bullish•Terumo Corp
•14 Dec 2022 18:40

Terumo Corp (4543 JP): H1FY23 Results Reflect Continued Recovery from the Pandemic

Terumo is on a strong double-digit revenue growth path due to continued COVID-related recovery of the procedure volume globally. The company should...

Logo
587 Views
Share
bullish•Asahi Intecc
•13 Jun 2022 00:42

Asahi Intecc (7747 JP): Recovery From COVID-19 to Drive Double-Digit Revenue Growth in Near-Term

Asahi Intecc is well-positioned for a revenue CAGR of 12% during FY21–26, driven by recovery from the impact of COVID, market share gain of...

Logo
603 Views
Share
bullish•Olympus Corp
•13 May 2022 00:54

Olympus (7733 JP) Q4FY22: Net Profit More Than Doubled; Record High Profit Projection for FY23

Olympus reported strong 0FY22 performance, ahead of its guidance. FY23 guidance is better than expectations, with net profit expected to reach a...

Logo
465 Views
Share
bearish•PHC Holdings
•29 Sep 2021 12:05

PHC Holdings IPO - Should Have Cut the Price, Not Just the Size

PHC Holdings and its shareholders aim to raise around US$700m, down from US$1.8bn, via selling a mix of primary and secondary shares in its Japan IPO.

Logo
506 Views
Share
bearish•PHC Holdings
•15 Sep 2021 15:17

PHC Holdings Pre-IPO - Peer Comparison

PHC Holdings and its shareholders aim to raise around US$1.8bn via selling a mix of primary and secondary shares in its Japan IPO. The company is...

Logo
405 Views
Share
x